Table 3.
IC50 (in nM) of carfilzomib formulations upon 48 h incubation with MM cells.
| MM1.S | L363 | UM-9 | |
|---|---|---|---|
| CFZ-PM | 5.3 | 6.8 | 6.1 |
| CFZ-CD | 3.1 | 3.8 | 3.7 |
| CFZ free | 2.8 | 3.5 | 3.4 |
IC50 (in nM) of carfilzomib formulations upon 48 h incubation with MM cells.
| MM1.S | L363 | UM-9 | |
|---|---|---|---|
| CFZ-PM | 5.3 | 6.8 | 6.1 |
| CFZ-CD | 3.1 | 3.8 | 3.7 |
| CFZ free | 2.8 | 3.5 | 3.4 |